Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Reviva Pharmaceuticals Holdings Inc RVPH

Healthcare Biotechnology
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system and respiratory and metabolic diseases. Its pipeline includes two drug candidates, RP5063 (brilaroxazine) and RP1208. Its lead drug... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:RVPH)

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

GlobeNewswire January 7, 2025

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

GlobeNewswire December 20, 2024

Reviva Announces Pricing of $18.0 Million Public Offering of Common Stock and Warrants

GlobeNewswire December 16, 2024

Reviva Announces Proposed Public Offering

GlobeNewswire December 16, 2024

Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia

GlobeNewswire December 16, 2024

Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire November 14, 2024

Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

GlobeNewswire November 12, 2024

Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024

GlobeNewswire November 6, 2024

Reviva to Participate in the UBS Global Healthcare Conference

GlobeNewswire October 31, 2024
View More News ››

Opinion & Analysis (NDAQ:RVPH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RVPH)

Have they closed the $18 million public offering?

Just wondering because I don't see any news release that it was closed.
Adwari - 5 hours ago

BA, RVPH, SSRM, REAL, MGX showing five-day upward surge

JUST IN: $RVPH BA, RVPH, SSRM, REAL, MGX showing five-day upward surge2024-12-11 09:44:23 ET Boeing Co. (BA) BA is trading UP for the...
whytestocks - December 11, 2024

Reviva Pharmaceuticals to Participate in the Lytham Partners

NEWS: $RVPH Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor ConferenceCUPERTINO, Calif., Sept. 26, 2024 ...
whytestocks - September 26, 2024

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH): A Late-

http://beyondspx.com/2024/07/31/reviva-pharmaceuticals-holdings-inc-nasdaqrvph-a-late-stage-biopharma-advancing-novel-therapies-for-unmet...
MikeTester - August 2, 2024

Reviva Announces $3 Million Registered Direct Offering Price

BREAKING NEWS: $RVPH Reviva Announces $3 Million Registered Direct Offering Priced&#xA0;At-the-Market&#xA0;Under Nasdaq...
whytestocks - May 28, 2024

Reviva Reports Full Year 2023 Financial Results and Recent B

Breaking News: $RVPH Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights@ RECOVER-1 Phase 3 global trial...
whytestocks - April 15, 2024
View more Bullboard ››

Forsys Metals Corp

Forsys Metals Corp

Forsys Metals Corp. is a Canada-based uranium developer. The Company is engaged in the acquisition, exploration and ...
View More »